Researchers analyzed the association between cancer care expenditures and age-standardized population-level cancer mortality rates in 22 high-income countries in 2020.
“The U.S. is spending over $200 billion per year on cancer care — roughly $600 per person, in comparison to the average of $300 per person across other high-income countries,” said Cary Gross, MD, senior author and professor of medicine and director of the National Clinician Scholars Program at New Haven, Conn.-based Yale University. “This raises the key question: Are we getting our money’s worth?”
Researchers found that six countries — Australia, Finland, Iceland, Japan, Korea and Switzerland — had both lower cancer mortality and lower spending than the U.S. Nine countries — Australia, Finland, Iceland, Japan, Korea, Luxembourg, Norway, Spain and Switzerland — had lower smoking-adjusted cancer mortality than the U.S., despite the U.S. having lower smoking rates than many other countries.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
